期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 98, 期 12, 页码 6668-6673出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.111155798
关键词
-
资金
- NCI NIH HHS [CA73740] Funding Source: Medline
The transcription factor NF-kappaB regulates expression of genes that are involved in inflammation, immune response, viral infection, cell survival, and division. However. the role of NF-kappaB in hypertrophic: growth of terminally differentiated cardiomyocytes is unknown. Here we report that NF-kappaB activation is required for hypertrophic growth of cardiomyocytes. In cultured rat primary neonatal ventricular cardiomyocytes, the nuclear translocation of NF-kappaB and its transcriptional activity were stimulated by several hypertrophic agonists, including phenylephrine. endothelin-1, and angiotensin II. The activation of NF-kappaB was inhibited by expression of a supersuppressor I kappaB alpha mutant that is resistant to stimulation-induced degradation and a dominant negative I kappaB kinase (IKK beta) mutant that can no longer be activated by phosphorylation. Furthermore, treatment with phenylephrine induced I kappaB alpha degradation in an IKK-dependent manner, suggesting that NF-kappaB is a downstream target of the hypertrophic agonists. Importantly, expression of the supersuppressor I kappaB alpha mutant or the dominant negative IKK beta mutant blocked the hypertrophic agonist-induced expression of the embryonic gene atrial natriuretic factor and enlargement of cardiomyocytes. Conversely, overexpression of NF-kappaB itself induced atrial natriuretic factor expression and cardiomyocyte enlargement. These findings suggest that NF-kappaB plays a critical role in the hypertrophic growth of cardiomyocytes and may serve as a potential target for the intervention of heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据